Free Trial

Annovis Bio (ANVS) Short Interest Ratio & Short Volume

Annovis Bio logo
$6.49 -0.05 (-0.76%)
(As of 10:15 AM ET)

Annovis Bio Short Interest Data

Annovis Bio (ANVS) has a short interest of 1.40 million shares. This marks a 2.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.8, indicating that it would take 5.8 days of the average trading volume of 752,965 shares to cover all short positions.

Current Short Interest
1,400,000 shares
Previous Short Interest
1,360,000 shares
Change Vs. Previous Month
+2.94%
Dollar Volume Sold Short
$13.02 million
Short Interest Ratio
5.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
13,800,000 shares
Percentage of Shares Shorted
10.14%
Today's Trading Volume
19,596 shares
Average Trading Volume
752,965 shares
Today's Volume Vs. Average
3%
Short Selling Annovis Bio?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Annovis Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ANVS Short Interest Over Time

ANVS Days to Cover Over Time

ANVS Percentage of Float Shorted Over Time

Annovis Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,400,000 shares $13.02 million +2.9%N/A5.8 $9.30
10/15/20241,360,000 shares $10.85 million +12.4%N/A5.5 $7.98
9/30/20241,210,000 shares $9.79 million +0.8%N/A3.7 $8.09
9/15/20241,200,000 shares $9.61 million -4.8%N/A0.7 $8.01
8/31/20241,260,000 shares $10.66 million -18.7%N/A0.7 $8.46
8/15/20241,550,000 shares $13.73 million +4.7%N/A0.9 $8.86
7/31/20241,480,000 shares $13.81 million -3.9%N/A0.8 $9.33
7/15/20241,540,000 shares $19.40 million +15.8%N/A0.8 $12.60
6/30/20241,330,000 shares $7.66 million +3.9%N/A0.7 $5.76
6/15/20241,280,000 shares $7.49 million +5.8%N/A2.5 $5.85
5/31/20241,210,000 shares $7.93 million -18.2%N/A2.2 $6.55
5/15/20241,480,000 shares $12.95 million -8.1%N/A2.8 $8.75
4/30/20241,610,000 shares $8.89 million +11.0%N/A3.6 $5.52
4/15/20241,450,000 shares $16.11 million -3.3%N/A5.9 $11.11
3/31/20241,500,000 shares $17.85 million +11.1%N/A5.6 $11.90
3/15/20241,350,000 shares $12.30 million -8.2%17.3%4.2 $9.11
2/29/20241,470,000 shares $12.45 million +7.3%19.1%5 $8.47
2/15/20241,370,000 shares $15.43 million +4.6%18.0%4.2 $11.26
1/31/20241,310,000 shares $14.45 million +33.7%17.2%4.3 $11.03
1/15/2024980,200 shares $12.59 million +1.7%13.3%3.7 $12.84
12/31/2023963,800 shares $18.02 million +51.6%13.0%4 $18.70
12/15/2023635,600 shares $6.93 million +21.2%8.6%3.5 $10.90
11/30/2023524,500 shares $4.45 million +8.9%7.5%4 $8.49
11/15/2023481,700 shares $2.88 million -7.7%6.9%6.2 $5.97
10/31/2023521,700 shares $3.42 million +23.3%7.2%9.7 $6.56
10/15/2023423,300 shares $3.33 million +25.4%6.7%10.4 $7.86
9/30/2023337,600 shares $3.20 million -8.6%5.3%12.2 $9.49
9/15/2023369,200 shares $3.91 million +6.1%5.8%12.9 $10.60
8/31/2023348,000 shares $4.32 million -5.3%5.5%14.3 $12.40
8/15/2023367,500 shares $4.72 million -2.1%5.8%13.3 $12.83
7/31/2023375,400 shares $5.18 million -9.4%5.9%12.8 $13.79
7/15/2023414,300 shares $5.73 million +1.9%6.5%12.7 $13.82
6/30/2023406,600 shares $5.79 million -5.8%6.4%9.6 $14.25
6/15/2023431,800 shares $6.36 million +11.1%6.8%5.2 $14.74
5/31/2023388,800 shares $5.09 million -1.2%6.4%4.5 $13.10
5/15/2023393,700 shares $5.45 million -20.8%6.5%4.7 $13.85
4/30/2023496,900 shares $7.24 million +6.7%8.2%5.6 $14.57
4/15/2023465,700 shares $7.00 million +30.1%8.4%4.5 $15.03
3/31/2023357,900 shares $5.52 million +39.6%6.4%3.7 $15.41
3/15/2023256,400 shares $4.06 million +2.9%4.6%4.6 $15.84
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

2/28/2023249,200 shares $4.26 million +6.6%4.5%4.7 $17.11
2/15/2023233,800 shares $4.03 million +22.4%4.2%4.5 $17.22
1/31/2023191,000 shares $3.16 million -1.6%3.4%4.1 $16.52
1/15/2023194,100 shares $2.49 million -2.1%3.4%6.8 $12.81
12/30/2022198,300 shares $2.66 million +21.9%3.5%6.3 $13.43
12/15/2022162,700 shares $1.98 million -4.4%2.9%3.9 $12.16
11/30/2022170,100 shares $2.29 million +7.7%3.0%2.3 $13.44
11/15/2022158,000 shares $2.14 million -11.2%2.8%2.1 $13.55
10/31/2022178,000 shares $2.23 million -9.6%3.2%2.3 $12.55
10/15/2022197,000 shares $2.46 million +13.0%3.5%2.5 $12.50
9/30/2022174,400 shares $2.39 million -22.7%3.1%2 $13.70
9/15/2022225,700 shares $4.92 million +47.5%4.0%2.1 $21.81
8/31/2022153,000 shares $1.77 million -6.5%2.7%1.9 $11.60
8/15/2022163,700 shares $2.03 million -15.8%2.9%2.2 $12.42
7/31/2022194,300 shares $2.23 million -21.6%3.5%2.6 $11.50
7/15/2022247,900 shares $3.20 million +33.9%4.4%3.2 $12.89
6/30/2022185,100 shares $2.10 million -1.6%3.3%2.5 $11.34
6/15/2022188,100 shares $1.93 million +8.3%3.3%4.7 $10.26
5/31/2022173,700 shares $1.59 million -3.4%3.1%4.3 $9.18
5/15/2022179,800 shares $1.69 million +3.9%3.2%4.4 $9.42
4/30/2022173,100 shares $1.63 million -21.9%3.1%3.8 $9.44
4/15/2022221,500 shares $2.92 million -20.8%3.9%3.8 $13.19
3/31/2022279,600 shares $3.73 million -19.4%5.0%4.2 $13.35
3/15/2022346,800 shares $4.36 million -10.4%6.2%4.1 $12.58
2/28/2022387,100 shares $5.50 million -10.6%6.9%4 $14.20
2/15/2022432,900 shares $6.50 million -6.6%7.8%4.1 $15.01
1/31/2022463,700 shares $7.03 million +5.2%8.3%3.4 $15.17
1/15/2022441,000 shares $6.84 million +11.9%8.1%2.7 $15.52
12/31/2021394,100 shares $6.93 million -8.0%7.2%2.3 $17.58

ANVS Short Interest - Frequently Asked Questions

What is Annovis Bio's current short interest?

Short interest is the volume of Annovis Bio shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,400,000 shares of ANVS short. Learn More on Annovis Bio's current short interest.

What is a good short interest ratio for Annovis Bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANVS shares currently have a short interest ratio of 6.0. Learn More on Annovis Bio's short interest ratio.

Which institutional investors are shorting Annovis Bio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Annovis Bio: Ikarian Capital LLC, LMR Partners LLP, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Annovis Bio's short interest increasing or decreasing?

Annovis Bio saw a increase in short interest in October. As of October 31st, there was short interest totaling 1,400,000 shares, an increase of 2.9% from the previous total of 1,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Annovis Bio's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Annovis Bio: Amylyx Pharmaceuticals, Inc. (3.13%), Alector, Inc. (6.24%), Ginkgo Bioworks Holdings, Inc. (20.69%), Contineum Therapeutics, Inc. (7.90%), Kamada Ltd. (0.09%), Q32 Bio Inc. (15.96%), biote Corp. (2.70%), SNDL Inc. (1.85%), Cryoport, Inc. (6.10%), AC Immune SA (1.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Annovis Bio stock?

Short selling ANVS is an investing strategy that aims to generate trading profit from Annovis Bio as its price is falling. ANVS shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Annovis Bio?

A short squeeze for Annovis Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANVS, which in turn drives the price of the stock up even further.

How often is Annovis Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANVS, twice per month. The most recent reporting period available is October, 31 2024.




This page (NYSE:ANVS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners